Login / Signup

Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study.

Gianni CarraroValentina Di VicoLoris MartinettiElisabetta BettinMartina CacciapuotiLucia Federica StefanelliLaura GobbiFederico NalessoFrancesca Katiana MartinoLorenzo Arcangelo Calò
Published in: Clinical drug investigation (2024)
Keyphrases
  • polycystic kidney disease
  • ejection fraction